Agenus Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include LogicBio Therapeutics.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
LogicBio Therapeutics
LogicBio Therapeutics
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
Founding Date
Founding Date
2018
Founding Date
2014
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Lexington, US HQ
Louisville, US
Employees
Employees
188
Employees
4178% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
176.3 m

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$5.4m (FY, 2021)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($40m) (FY, 2021)
For sources of this data, please see the company profile

View Company Profiles

LogicBio Therapeutics
HQ
Lexington, US
Employees
41

LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.

View company